Overview

Trading in options of Denali Therapeutics Inc. (NASDAQ: DNLI) increased to 2,291 contracts as of 2:10 p.m. New York time on Thursday, according to exchange data compiled by Bloomberg.

Option Activity Breakdown

Call contracts accounted for 1,863 of the total, while put contracts made up the remaining 428 contracts in the trading activity. The July 17 2026 $30 call option represented 1,535 contracts, and its open interest stood at 10 contracts as of Wednesday.

Equity Price and Volatility

Denali Therapeutics shares rose 0.36% to $24.91. The company's three‑month historical volatility rose by 17.02 percentage points to 86.41%, and the three‑month 90/110 skew increased by 9.74 percentage points to 8.53 percentage points.

Source Note

The article was generated with AI assistance and reviewed by an editor; see Reuters T&C for details.